Thermo Fisher Scientific Overview
Thermo Fisher Scientific Target Price
Analysts' 12-month price predictions for TMO.
Share Price
$492.6
Average Target Price
$460.00
6.6% downside
6.6% downside1 analysts in the last 4 months
High: $460 | Low: $460
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-08 | UBSDan Leonard | $460 | 6.6% downside |  |
| 2025-04-25 | Scotiabank | $605 |  22.8% upside | |
| 2025-04-23 | Goldman SachsMatthew Sykes | $610 | 23.8% upside | |
| 2025-01-31 | RBC CapitalConor McNamara | $693 | 40.7% upside | |
| 2025-01-02 | Evercore ISIVijay Kumar | $585 | 18.8% upside | |
| 2024-10-24 | Robert W. BairdCatherine Schulte | $622 | 26.3% upside | |
| 2024-10-23 | BarclaysLuke Sergott | $610 | 23.8% upside | |
| 2024-10-01 | Evercore ISIVijay Kumar | $630 | 27.9% upside | |
| 2024-09-20 | Stifel NicolausDaniel Arias | $680 | 38% upside | |
| 2024-09-20 | Robert W. BairdCatherine Schulte | $632 | 28.3% upside | |
| 2024-09-19 | CitigroupPatrick Donnelly | $620 | 25.9% upside | |
| 2024-09-18 | Deutsche BankJustin Bowers | $630 | 27.9% upside | |
| 2024-09-16 | Bank of America SecuritiesDerik de Bruin | $675 | 37% upside | |
| 2024-07-25 | Raymond JamesAndrew Cooper | $660 | 34% upside | |
| 2024-06-28 | BarclaysLuke Sergott | $600 | 21.8% upside | |
| 2024-04-30 | HSBCSidharth Sahoo | $670 | 36% upside | |
| 2024-04-25 | Deutsche BankJustin Bowers | $610 | 23.8% upside | |
| 2024-04-25 | BarclaysLuke Sergott | $615 | 24.8% upside | |
| 2023-12-28 | Robert W. BairdCatherine Schulte | $670 | 36% upside | |
| 2023-10-26 | Raymond JamesAndrew Cooper | $530 | 7.6% upside | |
| 2023-07-13 | Credit SuisseThermo Fisher | $620 | 25.9% upside | |
| 2023-02-02 | Cowen & Co. | $711 | 44.3% upside | |
| 2023-02-02 | Citigroup | $700 | 42.1% upside | |
| 2023-02-02 | Barclays | $660 | 34% upside | |
| 2023-02-02 | Leerink Partners | $630 | 27.9% upside | |
| 2023-01-06 | Leerink Partners | $620 | 25.9% upside | |
| 2023-01-03 | Wells Fargo | $505 | 2.5% upside | |
| 2022-12-14 | Deutsche Bank | $620 | 25.9% upside | |
| 2022-12-07 | RBC Capital | $661 | 34.2% upside | |
| 2022-11-29 | Barclays | $570 | 15.7% upside | |
| 2022-09-12 | Barclays | $595 | 20.8% upside | |
| 2022-08-04 | BarclaysLuke Sergott | $685 | 39.1% upside | |
| 2022-07-29 | Morgan Stanley | $678 | 37.6% upside | |
| 2022-07-29 | Leerink Partners | $650 | 32% upside | |
| 2022-07-13 | Barclays | $630 | 27.9% upside | |
| 2022-04-29 | Morgan Stanley | $670 | 36% upside | |
| 2022-04-25 | Wells Fargo | $525 | 6.6% upside | |
| 2021-10-28 | Morgan StanleyTejas Savant | $700 | 42.1% upside | |
| 2021-10-27 | Benchmark Co.Robert Wasserman | $650 | 32% upside | |
| 2021-09-23 | Goldman SachsMatthew Sykes | $690 | 40.1% upside | |
| 2021-09-20 | KeyBancPaul Knight | $710 | 44.1% upside | |
| 2021-09-20 | JefferiesBrandon Couillard | $540 | 9.6% upside | |
| 2021-09-20 | Bank of America SecuritiesDerik De Bruin | $670 | 36% upside | |
| 2021-09-20 | J.P. MorganTycho Peterson | $700 | 42.1% upside | |
| 2021-08-04 | Argus ResearchDavid Toung | $600 | 21.8% upside | |